Please login to the form below
Sanofi takes to Twitter to support Spanish pharmacy portal
Says new account on the social network will help support community pharmacists
Menarini launches urology campaign in Greece
PE information push includes Not Just A Moment website
GSK gets OK in US for diabetes drug albiglutide
Once-weekly Tanzeum will compete against Victoza and Byetta after FDA approval
Boehringer plans to open trial data back to 1998
Will partner with Sanofi, GSK, Roche, Novartis and ViiV Healthcare on online platform
Lilly and Alexion boost pharma jobs in Ireland
Between them the firms will create up to 300 new jobs
Merck gets US green light for allergy immunotherapy
Expected to provide a significant boost to company's partner Alk-Abello
BMS files fixed-dose HIV combination in US
Combines Reyataz with Gilead Sciences' cobicistat
HRW to expand into the US
Will open east coast office in May
Oral hepatitis C regimens tackle advanced liver disease
New data released at the International Liver Congress by AbbVie, Merck & Co and Gilead
This month in 1917: A tale of two Mercks
US enters World War I severing ties between Merck & Co and its German parent
-
Hollow victory: the dangers of successHow success can trap companies and make them vulnerable to competition
-
Back to mobile basicsTexting as part of a wider healthcare plan
-
GSK under investigation in Poland for 'camouflaged bribes'A regional manager and 11 doctors have been charged, according to a BBC report
-
Pharma shares data on cancer projects Project Data Sphere involves AZ, Bayer, Celgene, Janssen, Pfizer and Sanofi
-
Herceptin could face biosimilars in UK later this yearCourt overturns patents protecting Roche’s cancer drug
-
Lilly to use real-world data in diabetes collaborationPartners with T1D Exchange to research ways to provide type 1 diabetes care
-
Publicis boosts South Africa presenceAgency acquires local creative agency OwenKessel
-
Roche challenges Tamiflu findingsDenies claims that UK government wasted millions on flu drug
-
WHO raises red flag on hepatitis C drug pricingWarns about cost of Gilead’s Sovaldi and J&J’s Olysio
Latest appointments
-
Polyhedra appoints Steve Hobbs chief business development officerHe joins the group from Apodi
-
Hall & Partners boosts senior health teamAppoints Jeanette Hodgson and promotes Marie Bennett
-
Pfizer’s Emms takes up ABPI presidencyHe succeeds MSD’s Deepak Khanna at the UK pharma industry body
-
inVentiv Health appoints head of commercial and consultingMichael Griffith is former CEO of Laureate Biopharma
-
Changing the guard at Novartis' Sandoz and Alcon unitsRichard Francis joins from Biogen Idec and Kevin Buehler retires
Featured jobs
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
- Brand Manager GI Cancers
- On application
- Senior Account Executive- Med Coms, London
- Competitive Salary Offered
- Communications Manager
- On application
- Senior Account Manager- Med Comms, London
- Competitive Salary Offered
Subscribe to our email news alerts
PMHub
Galbraith Wight
The GalbraithWight Business School deliver boths in-house and public training programmes including the only accredited diploma designed specifically to enable...
Latest intelligence
- England’s clinical commissioning landscape
- Who are the real masters in the new NHS?...
- How will the new landscape of Hep C treatments affect patients?
- The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
- Pharma deals during March 2014
- Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...
Quick links
